nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—schizophrenia—Dimenhydrinate—atopic dermatitis	0.22	0.569	CpDpCtD
Fluoxetine—schizophrenia—Diphenhydramine—atopic dermatitis	0.167	0.431	CpDpCtD
Fluoxetine—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.0747	0.318	CrCrCtD
Fluoxetine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0587	0.25	CrCrCtD
Fluoxetine—ORM1—Tacrolimus—atopic dermatitis	0.0464	0.17	CbGbCtD
Fluoxetine—Atomoxetine—Diphenhydramine—atopic dermatitis	0.0379	0.162	CrCrCtD
Fluoxetine—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.0355	0.151	CrCrCtD
Fluoxetine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.0279	0.119	CrCrCtD
Fluoxetine—ALB—Tacrolimus—atopic dermatitis	0.0195	0.0713	CbGbCtD
Fluoxetine—CYP3A5—Tacrolimus—atopic dermatitis	0.0157	0.0573	CbGbCtD
Fluoxetine—CYP2B6—Diphenhydramine—atopic dermatitis	0.0146	0.0533	CbGbCtD
Fluoxetine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0103	0.0376	CbGbCtD
Fluoxetine—ABCB1—Tacrolimus—atopic dermatitis	0.0102	0.0373	CbGbCtD
Fluoxetine—CYP2C19—Loratadine—atopic dermatitis	0.00926	0.0338	CbGbCtD
Fluoxetine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00926	0.0338	CbGbCtD
Fluoxetine—CYP1A2—Diphenhydramine—atopic dermatitis	0.00855	0.0312	CbGbCtD
Fluoxetine—ALB—Prednisone—atopic dermatitis	0.00792	0.0289	CbGbCtD
Fluoxetine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0077	0.0281	CbGbCtD
Fluoxetine—CYP2C9—Loratadine—atopic dermatitis	0.0077	0.0281	CbGbCtD
Fluoxetine—ABCB1—Loratadine—atopic dermatitis	0.00748	0.0273	CbGbCtD
Fluoxetine—CYP2D6—Loratadine—atopic dermatitis	0.00704	0.0257	CbGbCtD
Fluoxetine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00704	0.0257	CbGbCtD
Fluoxetine—ABCB1—Methylprednisolone—atopic dermatitis	0.00684	0.025	CbGbCtD
Fluoxetine—CYP3A5—Hydrocortisone—atopic dermatitis	0.00639	0.0233	CbGbCtD
Fluoxetine—CYP3A4—Tacrolimus—atopic dermatitis	0.00612	0.0224	CbGbCtD
Fluoxetine—CYP2C19—Prednisone—atopic dermatitis	0.00513	0.0188	CbGbCtD
Fluoxetine—CYP2B6—Dexamethasone—atopic dermatitis	0.00504	0.0184	CbGbCtD
Fluoxetine—CYP3A4—Loratadine—atopic dermatitis	0.00448	0.0164	CbGbCtD
Fluoxetine—ABCB1—Betamethasone—atopic dermatitis	0.00445	0.0162	CbGbCtD
Fluoxetine—ABCB1—Prednisolone—atopic dermatitis	0.00439	0.016	CbGbCtD
Fluoxetine—ABCB1—Hydrocortisone—atopic dermatitis	0.00416	0.0152	CbGbCtD
Fluoxetine—ABCB1—Prednisone—atopic dermatitis	0.00414	0.0151	CbGbCtD
Fluoxetine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0041	0.015	CbGbCtD
Fluoxetine—CYP3A5—Dexamethasone—atopic dermatitis	0.00397	0.0145	CbGbCtD
Fluoxetine—CYP2C19—Dexamethasone—atopic dermatitis	0.0032	0.0117	CbGbCtD
Fluoxetine—CYP3A4—Triamcinolone—atopic dermatitis	0.0031	0.0113	CbGbCtD
Fluoxetine—CYP2C9—Dexamethasone—atopic dermatitis	0.00266	0.00973	CbGbCtD
Fluoxetine—CYP3A4—Betamethasone—atopic dermatitis	0.00266	0.00973	CbGbCtD
Fluoxetine—CYP3A4—Prednisolone—atopic dermatitis	0.00263	0.0096	CbGbCtD
Fluoxetine—ABCB1—Dexamethasone—atopic dermatitis	0.00259	0.00945	CbGbCtD
Fluoxetine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00249	0.0091	CbGbCtD
Fluoxetine—CYP3A4—Prednisone—atopic dermatitis	0.00248	0.00907	CbGbCtD
Fluoxetine—CYP2D6—Dexamethasone—atopic dermatitis	0.00244	0.0089	CbGbCtD
Fluoxetine—CYP3A4—Dexamethasone—atopic dermatitis	0.00155	0.00566	CbGbCtD
Fluoxetine—SIGMAR1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000361	1	CbGdCrCtD
Fluoxetine—Vertigo—Methylprednisolone—atopic dermatitis	2.7e-05	0.000258	CcSEcCtD
Fluoxetine—Syncope—Methylprednisolone—atopic dermatitis	2.69e-05	0.000257	CcSEcCtD
Fluoxetine—Discomfort—Hydrocortisone—atopic dermatitis	2.69e-05	0.000257	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisolone—atopic dermatitis	2.67e-05	0.000255	CcSEcCtD
Fluoxetine—Vomiting—Tacrolimus—atopic dermatitis	2.66e-05	0.000254	CcSEcCtD
Fluoxetine—Loss of consciousness—Triamcinolone—atopic dermatitis	2.65e-05	0.000253	CcSEcCtD
Fluoxetine—Loss of consciousness—Methylprednisolone—atopic dermatitis	2.64e-05	0.000252	CcSEcCtD
Fluoxetine—Rash—Tacrolimus—atopic dermatitis	2.64e-05	0.000252	CcSEcCtD
Fluoxetine—Dermatitis—Tacrolimus—atopic dermatitis	2.64e-05	0.000251	CcSEcCtD
Fluoxetine—Shock—Prednisolone—atopic dermatitis	2.63e-05	0.000251	CcSEcCtD
Fluoxetine—Cough—Triamcinolone—atopic dermatitis	2.63e-05	0.000251	CcSEcCtD
Fluoxetine—Headache—Tacrolimus—atopic dermatitis	2.62e-05	0.00025	CcSEcCtD
Fluoxetine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	2.61e-05	0.000249	CcSEcCtD
Fluoxetine—Convulsion—Triamcinolone—atopic dermatitis	2.61e-05	0.000249	CcSEcCtD
Fluoxetine—Tachycardia—Prednisolone—atopic dermatitis	2.61e-05	0.000249	CcSEcCtD
Fluoxetine—Convulsion—Methylprednisolone—atopic dermatitis	2.6e-05	0.000248	CcSEcCtD
Fluoxetine—Hypertension—Triamcinolone—atopic dermatitis	2.6e-05	0.000248	CcSEcCtD
Fluoxetine—Hypertension—Methylprednisolone—atopic dermatitis	2.59e-05	0.000247	CcSEcCtD
Fluoxetine—Infection—Hydrocortisone—atopic dermatitis	2.59e-05	0.000247	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisolone—atopic dermatitis	2.58e-05	0.000246	CcSEcCtD
Fluoxetine—Shock—Hydrocortisone—atopic dermatitis	2.57e-05	0.000245	CcSEcCtD
Fluoxetine—Myalgia—Triamcinolone—atopic dermatitis	2.56e-05	0.000245	CcSEcCtD
Fluoxetine—Arthralgia—Methylprednisolone—atopic dermatitis	2.56e-05	0.000244	CcSEcCtD
Fluoxetine—Myalgia—Methylprednisolone—atopic dermatitis	2.56e-05	0.000244	CcSEcCtD
Fluoxetine—Anxiety—Methylprednisolone—atopic dermatitis	2.55e-05	0.000243	CcSEcCtD
Fluoxetine—Tachycardia—Hydrocortisone—atopic dermatitis	2.55e-05	0.000243	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	2.54e-05	0.000242	CcSEcCtD
Fluoxetine—Skin disorder—Hydrocortisone—atopic dermatitis	2.54e-05	0.000242	CcSEcCtD
Fluoxetine—Ill-defined disorder—Dexamethasone—atopic dermatitis	2.54e-05	0.000242	CcSEcCtD
Fluoxetine—Ill-defined disorder—Betamethasone—atopic dermatitis	2.54e-05	0.000242	CcSEcCtD
Fluoxetine—Discomfort—Triamcinolone—atopic dermatitis	2.53e-05	0.000242	CcSEcCtD
Fluoxetine—Discomfort—Methylprednisolone—atopic dermatitis	2.53e-05	0.000241	CcSEcCtD
Fluoxetine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	2.52e-05	0.000241	CcSEcCtD
Fluoxetine—Dry mouth—Triamcinolone—atopic dermatitis	2.51e-05	0.000239	CcSEcCtD
Fluoxetine—Angioedema—Betamethasone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Fluoxetine—Angioedema—Dexamethasone—atopic dermatitis	2.5e-05	0.000238	CcSEcCtD
Fluoxetine—Anorexia—Hydrocortisone—atopic dermatitis	2.49e-05	0.000237	CcSEcCtD
Fluoxetine—Nausea—Tacrolimus—atopic dermatitis	2.49e-05	0.000237	CcSEcCtD
Fluoxetine—Confusional state—Methylprednisolone—atopic dermatitis	2.47e-05	0.000236	CcSEcCtD
Fluoxetine—Malaise—Betamethasone—atopic dermatitis	2.46e-05	0.000235	CcSEcCtD
Fluoxetine—Malaise—Dexamethasone—atopic dermatitis	2.46e-05	0.000235	CcSEcCtD
Fluoxetine—Anaphylactic shock—Triamcinolone—atopic dermatitis	2.46e-05	0.000234	CcSEcCtD
Fluoxetine—Vertigo—Betamethasone—atopic dermatitis	2.46e-05	0.000234	CcSEcCtD
Fluoxetine—Vertigo—Dexamethasone—atopic dermatitis	2.46e-05	0.000234	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	2.45e-05	0.000234	CcSEcCtD
Fluoxetine—Syncope—Betamethasone—atopic dermatitis	2.45e-05	0.000234	CcSEcCtD
Fluoxetine—Syncope—Dexamethasone—atopic dermatitis	2.45e-05	0.000234	CcSEcCtD
Fluoxetine—Arrhythmia—Prednisone—atopic dermatitis	2.44e-05	0.000233	CcSEcCtD
Fluoxetine—Infection—Triamcinolone—atopic dermatitis	2.44e-05	0.000233	CcSEcCtD
Fluoxetine—Hypotension—Hydrocortisone—atopic dermatitis	2.44e-05	0.000233	CcSEcCtD
Fluoxetine—Infection—Methylprednisolone—atopic dermatitis	2.44e-05	0.000232	CcSEcCtD
Fluoxetine—Shock—Triamcinolone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Fluoxetine—Insomnia—Prednisolone—atopic dermatitis	2.42e-05	0.000231	CcSEcCtD
Fluoxetine—Alopecia—Prednisone—atopic dermatitis	2.42e-05	0.00023	CcSEcCtD
Fluoxetine—Shock—Methylprednisolone—atopic dermatitis	2.41e-05	0.00023	CcSEcCtD
Fluoxetine—Loss of consciousness—Betamethasone—atopic dermatitis	2.4e-05	0.000229	CcSEcCtD
Fluoxetine—Loss of consciousness—Dexamethasone—atopic dermatitis	2.4e-05	0.000229	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisolone—atopic dermatitis	2.4e-05	0.000229	CcSEcCtD
Fluoxetine—Tachycardia—Triamcinolone—atopic dermatitis	2.4e-05	0.000229	CcSEcCtD
Fluoxetine—Mental disorder—Prednisone—atopic dermatitis	2.39e-05	0.000228	CcSEcCtD
Fluoxetine—Tachycardia—Methylprednisolone—atopic dermatitis	2.39e-05	0.000228	CcSEcCtD
Fluoxetine—Skin disorder—Methylprednisolone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Fluoxetine—Malnutrition—Prednisone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Fluoxetine—Hyperhidrosis—Triamcinolone—atopic dermatitis	2.38e-05	0.000227	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	2.37e-05	0.000226	CcSEcCtD
Fluoxetine—Convulsion—Dexamethasone—atopic dermatitis	2.37e-05	0.000226	CcSEcCtD
Fluoxetine—Convulsion—Betamethasone—atopic dermatitis	2.37e-05	0.000226	CcSEcCtD
Fluoxetine—Insomnia—Hydrocortisone—atopic dermatitis	2.36e-05	0.000225	CcSEcCtD
Fluoxetine—Hypertension—Dexamethasone—atopic dermatitis	2.36e-05	0.000225	CcSEcCtD
Fluoxetine—Hypertension—Betamethasone—atopic dermatitis	2.36e-05	0.000225	CcSEcCtD
Fluoxetine—Paraesthesia—Hydrocortisone—atopic dermatitis	2.34e-05	0.000224	CcSEcCtD
Fluoxetine—Myalgia—Betamethasone—atopic dermatitis	2.33e-05	0.000222	CcSEcCtD
Fluoxetine—Myalgia—Dexamethasone—atopic dermatitis	2.33e-05	0.000222	CcSEcCtD
Fluoxetine—Anxiety—Dexamethasone—atopic dermatitis	2.32e-05	0.000221	CcSEcCtD
Fluoxetine—Anxiety—Betamethasone—atopic dermatitis	2.32e-05	0.000221	CcSEcCtD
Fluoxetine—Discomfort—Betamethasone—atopic dermatitis	2.3e-05	0.000219	CcSEcCtD
Fluoxetine—Discomfort—Dexamethasone—atopic dermatitis	2.3e-05	0.000219	CcSEcCtD
Fluoxetine—Dyspepsia—Hydrocortisone—atopic dermatitis	2.3e-05	0.000219	CcSEcCtD
Fluoxetine—Hypotension—Methylprednisolone—atopic dermatitis	2.29e-05	0.000219	CcSEcCtD
Fluoxetine—Pain—Prednisolone—atopic dermatitis	2.29e-05	0.000218	CcSEcCtD
Fluoxetine—Decreased appetite—Hydrocortisone—atopic dermatitis	2.27e-05	0.000216	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2.25e-05	0.000215	CcSEcCtD
Fluoxetine—Fatigue—Hydrocortisone—atopic dermatitis	2.25e-05	0.000215	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	2.24e-05	0.000214	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	2.23e-05	0.000213	CcSEcCtD
Fluoxetine—Pain—Hydrocortisone—atopic dermatitis	2.23e-05	0.000213	CcSEcCtD
Fluoxetine—Anaphylactic shock—Betamethasone—atopic dermatitis	2.23e-05	0.000213	CcSEcCtD
Fluoxetine—Anaphylactic shock—Dexamethasone—atopic dermatitis	2.23e-05	0.000213	CcSEcCtD
Fluoxetine—Insomnia—Triamcinolone—atopic dermatitis	2.22e-05	0.000212	CcSEcCtD
Fluoxetine—Insomnia—Methylprednisolone—atopic dermatitis	2.22e-05	0.000212	CcSEcCtD
Fluoxetine—Infection—Betamethasone—atopic dermatitis	2.22e-05	0.000211	CcSEcCtD
Fluoxetine—Infection—Dexamethasone—atopic dermatitis	2.22e-05	0.000211	CcSEcCtD
Fluoxetine—Ill-defined disorder—Prednisone—atopic dermatitis	2.21e-05	0.000211	CcSEcCtD
Fluoxetine—Paraesthesia—Triamcinolone—atopic dermatitis	2.21e-05	0.000211	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisolone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Fluoxetine—Paraesthesia—Methylprednisolone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Fluoxetine—Anaemia—Prednisone—atopic dermatitis	2.2e-05	0.00021	CcSEcCtD
Fluoxetine—Shock—Dexamethasone—atopic dermatitis	2.19e-05	0.000209	CcSEcCtD
Fluoxetine—Shock—Betamethasone—atopic dermatitis	2.19e-05	0.000209	CcSEcCtD
Fluoxetine—Dyspnoea—Triamcinolone—atopic dermatitis	2.19e-05	0.000209	CcSEcCtD
Fluoxetine—Agitation—Prednisone—atopic dermatitis	2.19e-05	0.000209	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dexamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Fluoxetine—Tachycardia—Betamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Fluoxetine—Tachycardia—Dexamethasone—atopic dermatitis	2.18e-05	0.000208	CcSEcCtD
Fluoxetine—Angioedema—Prednisone—atopic dermatitis	2.17e-05	0.000207	CcSEcCtD
Fluoxetine—Dyspepsia—Triamcinolone—atopic dermatitis	2.16e-05	0.000206	CcSEcCtD
Fluoxetine—Dyspepsia—Methylprednisolone—atopic dermatitis	2.16e-05	0.000206	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betamethasone—atopic dermatitis	2.16e-05	0.000206	CcSEcCtD
Fluoxetine—Hyperhidrosis—Dexamethasone—atopic dermatitis	2.16e-05	0.000206	CcSEcCtD
Fluoxetine—Feeling abnormal—Hydrocortisone—atopic dermatitis	2.15e-05	0.000205	CcSEcCtD
Fluoxetine—Malaise—Prednisone—atopic dermatitis	2.15e-05	0.000205	CcSEcCtD
Fluoxetine—Vertigo—Prednisone—atopic dermatitis	2.14e-05	0.000204	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	2.13e-05	0.000204	CcSEcCtD
Fluoxetine—Syncope—Prednisone—atopic dermatitis	2.13e-05	0.000204	CcSEcCtD
Fluoxetine—Anorexia—Dexamethasone—atopic dermatitis	2.13e-05	0.000203	CcSEcCtD
Fluoxetine—Anorexia—Betamethasone—atopic dermatitis	2.13e-05	0.000203	CcSEcCtD
Fluoxetine—Urticaria—Prednisolone—atopic dermatitis	2.12e-05	0.000203	CcSEcCtD
Fluoxetine—Fatigue—Triamcinolone—atopic dermatitis	2.12e-05	0.000202	CcSEcCtD
Fluoxetine—Fatigue—Methylprednisolone—atopic dermatitis	2.11e-05	0.000202	CcSEcCtD
Fluoxetine—Pain—Triamcinolone—atopic dermatitis	2.1e-05	0.000201	CcSEcCtD
Fluoxetine—Loss of consciousness—Prednisone—atopic dermatitis	2.09e-05	0.0002	CcSEcCtD
Fluoxetine—Hypotension—Dexamethasone—atopic dermatitis	2.08e-05	0.000199	CcSEcCtD
Fluoxetine—Hypotension—Betamethasone—atopic dermatitis	2.08e-05	0.000199	CcSEcCtD
Fluoxetine—Urticaria—Hydrocortisone—atopic dermatitis	2.07e-05	0.000198	CcSEcCtD
Fluoxetine—Body temperature increased—Hydrocortisone—atopic dermatitis	2.06e-05	0.000197	CcSEcCtD
Fluoxetine—Abdominal pain—Hydrocortisone—atopic dermatitis	2.06e-05	0.000197	CcSEcCtD
Fluoxetine—Convulsion—Prednisone—atopic dermatitis	2.06e-05	0.000197	CcSEcCtD
Fluoxetine—Hypertension—Prednisone—atopic dermatitis	2.05e-05	0.000196	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	2.03e-05	0.000194	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	2.03e-05	0.000194	CcSEcCtD
Fluoxetine—Arthralgia—Prednisone—atopic dermatitis	2.03e-05	0.000193	CcSEcCtD
Fluoxetine—Myalgia—Prednisone—atopic dermatitis	2.03e-05	0.000193	CcSEcCtD
Fluoxetine—Feeling abnormal—Triamcinolone—atopic dermatitis	2.03e-05	0.000193	CcSEcCtD
Fluoxetine—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.02e-05	0.000193	CcSEcCtD
Fluoxetine—Anxiety—Prednisone—atopic dermatitis	2.02e-05	0.000193	CcSEcCtD
Fluoxetine—Insomnia—Dexamethasone—atopic dermatitis	2.02e-05	0.000192	CcSEcCtD
Fluoxetine—Insomnia—Betamethasone—atopic dermatitis	2.02e-05	0.000192	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.01e-05	0.000192	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.01e-05	0.000191	CcSEcCtD
Fluoxetine—Paraesthesia—Dexamethasone—atopic dermatitis	2e-05	0.000191	CcSEcCtD
Fluoxetine—Paraesthesia—Betamethasone—atopic dermatitis	2e-05	0.000191	CcSEcCtD
Fluoxetine—Discomfort—Prednisone—atopic dermatitis	2e-05	0.000191	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisolone—atopic dermatitis	1.97e-05	0.000188	CcSEcCtD
Fluoxetine—Dyspepsia—Dexamethasone—atopic dermatitis	1.96e-05	0.000187	CcSEcCtD
Fluoxetine—Dyspepsia—Betamethasone—atopic dermatitis	1.96e-05	0.000187	CcSEcCtD
Fluoxetine—Urticaria—Triamcinolone—atopic dermatitis	1.95e-05	0.000186	CcSEcCtD
Fluoxetine—Urticaria—Methylprednisolone—atopic dermatitis	1.95e-05	0.000186	CcSEcCtD
Fluoxetine—Body temperature increased—Triamcinolone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Fluoxetine—Abdominal pain—Methylprednisolone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Fluoxetine—Decreased appetite—Dexamethasone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Fluoxetine—Decreased appetite—Betamethasone—atopic dermatitis	1.94e-05	0.000185	CcSEcCtD
Fluoxetine—Infection—Prednisone—atopic dermatitis	1.93e-05	0.000184	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	1.93e-05	0.000184	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	1.93e-05	0.000184	CcSEcCtD
Fluoxetine—Hypersensitivity—Hydrocortisone—atopic dermatitis	1.92e-05	0.000183	CcSEcCtD
Fluoxetine—Fatigue—Dexamethasone—atopic dermatitis	1.92e-05	0.000183	CcSEcCtD
Fluoxetine—Fatigue—Betamethasone—atopic dermatitis	1.92e-05	0.000183	CcSEcCtD
Fluoxetine—Shock—Prednisone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Fluoxetine—Pain—Dexamethasone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Fluoxetine—Pain—Betamethasone—atopic dermatitis	1.91e-05	0.000182	CcSEcCtD
Fluoxetine—Tachycardia—Prednisone—atopic dermatitis	1.9e-05	0.000181	CcSEcCtD
Fluoxetine—Skin disorder—Prednisone—atopic dermatitis	1.89e-05	0.00018	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisone—atopic dermatitis	1.88e-05	0.000179	CcSEcCtD
Fluoxetine—Asthenia—Hydrocortisone—atopic dermatitis	1.87e-05	0.000179	CcSEcCtD
Fluoxetine—Anorexia—Prednisone—atopic dermatitis	1.85e-05	0.000177	CcSEcCtD
Fluoxetine—Pruritus—Hydrocortisone—atopic dermatitis	1.85e-05	0.000176	CcSEcCtD
Fluoxetine—Feeling abnormal—Betamethasone—atopic dermatitis	1.84e-05	0.000175	CcSEcCtD
Fluoxetine—Feeling abnormal—Dexamethasone—atopic dermatitis	1.84e-05	0.000175	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Betamethasone—atopic dermatitis	1.82e-05	0.000174	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	1.82e-05	0.000174	CcSEcCtD
Fluoxetine—Hypersensitivity—Triamcinolone—atopic dermatitis	1.81e-05	0.000173	CcSEcCtD
Fluoxetine—Hypersensitivity—Methylprednisolone—atopic dermatitis	1.81e-05	0.000172	CcSEcCtD
Fluoxetine—Diarrhoea—Hydrocortisone—atopic dermatitis	1.79e-05	0.00017	CcSEcCtD
Fluoxetine—Urticaria—Betamethasone—atopic dermatitis	1.77e-05	0.000169	CcSEcCtD
Fluoxetine—Urticaria—Dexamethasone—atopic dermatitis	1.77e-05	0.000169	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.77e-05	0.000169	CcSEcCtD
Fluoxetine—Dizziness—Prednisolone—atopic dermatitis	1.77e-05	0.000169	CcSEcCtD
Fluoxetine—Asthenia—Triamcinolone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Body temperature increased—Dexamethasone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Abdominal pain—Dexamethasone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Body temperature increased—Betamethasone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Abdominal pain—Betamethasone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Asthenia—Methylprednisolone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Insomnia—Prednisone—atopic dermatitis	1.76e-05	0.000168	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Fluoxetine—Pruritus—Triamcinolone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Fluoxetine—Pruritus—Methylprednisolone—atopic dermatitis	1.74e-05	0.000166	CcSEcCtD
Fluoxetine—Dizziness—Hydrocortisone—atopic dermatitis	1.73e-05	0.000165	CcSEcCtD
Fluoxetine—Dyspepsia—Prednisone—atopic dermatitis	1.71e-05	0.000163	CcSEcCtD
Fluoxetine—Decreased appetite—Prednisone—atopic dermatitis	1.69e-05	0.000161	CcSEcCtD
Fluoxetine—Rash—Prednisolone—atopic dermatitis	1.69e-05	0.000161	CcSEcCtD
Fluoxetine—Dermatitis—Prednisolone—atopic dermatitis	1.68e-05	0.000161	CcSEcCtD
Fluoxetine—Diarrhoea—Methylprednisolone—atopic dermatitis	1.68e-05	0.00016	CcSEcCtD
Fluoxetine—Fatigue—Prednisone—atopic dermatitis	1.67e-05	0.00016	CcSEcCtD
Fluoxetine—Headache—Prednisolone—atopic dermatitis	1.67e-05	0.00016	CcSEcCtD
Fluoxetine—Constipation—Prednisone—atopic dermatitis	1.66e-05	0.000158	CcSEcCtD
Fluoxetine—Vomiting—Hydrocortisone—atopic dermatitis	1.66e-05	0.000158	CcSEcCtD
Fluoxetine—Rash—Hydrocortisone—atopic dermatitis	1.65e-05	0.000157	CcSEcCtD
Fluoxetine—Dermatitis—Hydrocortisone—atopic dermatitis	1.64e-05	0.000157	CcSEcCtD
Fluoxetine—Headache—Hydrocortisone—atopic dermatitis	1.64e-05	0.000156	CcSEcCtD
Fluoxetine—Dizziness—Triamcinolone—atopic dermatitis	1.63e-05	0.000155	CcSEcCtD
Fluoxetine—Dizziness—Methylprednisolone—atopic dermatitis	1.62e-05	0.000155	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisone—atopic dermatitis	1.6e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Betamethasone—atopic dermatitis	1.6e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Dexamethasone—atopic dermatitis	1.6e-05	0.000153	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Prednisone—atopic dermatitis	1.59e-05	0.000152	CcSEcCtD
Fluoxetine—Nausea—Prednisolone—atopic dermatitis	1.59e-05	0.000151	CcSEcCtD
Fluoxetine—Pruritus—Betamethasone—atopic dermatitis	1.58e-05	0.000151	CcSEcCtD
Fluoxetine—Pruritus—Dexamethasone—atopic dermatitis	1.58e-05	0.000151	CcSEcCtD
Fluoxetine—Vomiting—Triamcinolone—atopic dermatitis	1.56e-05	0.000149	CcSEcCtD
Fluoxetine—Vomiting—Methylprednisolone—atopic dermatitis	1.56e-05	0.000149	CcSEcCtD
Fluoxetine—Nausea—Hydrocortisone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Fluoxetine—Rash—Triamcinolone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Fluoxetine—Dermatitis—Triamcinolone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Fluoxetine—Rash—Methylprednisolone—atopic dermatitis	1.55e-05	0.000148	CcSEcCtD
Fluoxetine—Dermatitis—Methylprednisolone—atopic dermatitis	1.54e-05	0.000147	CcSEcCtD
Fluoxetine—Urticaria—Prednisone—atopic dermatitis	1.54e-05	0.000147	CcSEcCtD
Fluoxetine—Headache—Triamcinolone—atopic dermatitis	1.54e-05	0.000147	CcSEcCtD
Fluoxetine—Headache—Methylprednisolone—atopic dermatitis	1.54e-05	0.000147	CcSEcCtD
Fluoxetine—Abdominal pain—Prednisone—atopic dermatitis	1.54e-05	0.000146	CcSEcCtD
Fluoxetine—Body temperature increased—Prednisone—atopic dermatitis	1.54e-05	0.000146	CcSEcCtD
Fluoxetine—Diarrhoea—Betamethasone—atopic dermatitis	1.53e-05	0.000146	CcSEcCtD
Fluoxetine—Diarrhoea—Dexamethasone—atopic dermatitis	1.53e-05	0.000146	CcSEcCtD
Fluoxetine—Dizziness—Betamethasone—atopic dermatitis	1.47e-05	0.000141	CcSEcCtD
Fluoxetine—Dizziness—Dexamethasone—atopic dermatitis	1.47e-05	0.000141	CcSEcCtD
Fluoxetine—Nausea—Triamcinolone—atopic dermatitis	1.46e-05	0.000139	CcSEcCtD
Fluoxetine—Nausea—Methylprednisolone—atopic dermatitis	1.46e-05	0.000139	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisone—atopic dermatitis	1.43e-05	0.000137	CcSEcCtD
Fluoxetine—Vomiting—Betamethasone—atopic dermatitis	1.42e-05	0.000135	CcSEcCtD
Fluoxetine—Vomiting—Dexamethasone—atopic dermatitis	1.42e-05	0.000135	CcSEcCtD
Fluoxetine—Rash—Dexamethasone—atopic dermatitis	1.41e-05	0.000134	CcSEcCtD
Fluoxetine—Rash—Betamethasone—atopic dermatitis	1.41e-05	0.000134	CcSEcCtD
Fluoxetine—Dermatitis—Dexamethasone—atopic dermatitis	1.4e-05	0.000134	CcSEcCtD
Fluoxetine—Dermatitis—Betamethasone—atopic dermatitis	1.4e-05	0.000134	CcSEcCtD
Fluoxetine—Headache—Dexamethasone—atopic dermatitis	1.4e-05	0.000133	CcSEcCtD
Fluoxetine—Headache—Betamethasone—atopic dermatitis	1.4e-05	0.000133	CcSEcCtD
Fluoxetine—Asthenia—Prednisone—atopic dermatitis	1.39e-05	0.000133	CcSEcCtD
Fluoxetine—Pruritus—Prednisone—atopic dermatitis	1.37e-05	0.000131	CcSEcCtD
Fluoxetine—Diarrhoea—Prednisone—atopic dermatitis	1.33e-05	0.000127	CcSEcCtD
Fluoxetine—Nausea—Betamethasone—atopic dermatitis	1.32e-05	0.000126	CcSEcCtD
Fluoxetine—Nausea—Dexamethasone—atopic dermatitis	1.32e-05	0.000126	CcSEcCtD
Fluoxetine—Dizziness—Prednisone—atopic dermatitis	1.28e-05	0.000123	CcSEcCtD
Fluoxetine—Vomiting—Prednisone—atopic dermatitis	1.23e-05	0.000118	CcSEcCtD
Fluoxetine—Rash—Prednisone—atopic dermatitis	1.22e-05	0.000117	CcSEcCtD
Fluoxetine—Dermatitis—Prednisone—atopic dermatitis	1.22e-05	0.000117	CcSEcCtD
Fluoxetine—Headache—Prednisone—atopic dermatitis	1.22e-05	0.000116	CcSEcCtD
Fluoxetine—Nausea—Prednisone—atopic dermatitis	1.15e-05	0.00011	CcSEcCtD
